Topspin Biotech Fund Ii, L.p.

ORIC

10% OWNER · ORIC PHARMACEUTICALS, INC. · CIK 0001745827

FILING MIX · LIFETIME44%/56%

BUYS

SELLS

TOTAL VALUE

COMPANIES

ACTIVE SINCE

Apr 2020

HOLDINGS NOW

1,100,446

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

1 backtested trades · 8 horizonsHow are these numbers computed? →

Forward-return performance of every backtestable P/S trade by Topspin Biotech Fund Ii, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	1	+0.00%	+6.83%	+3.83%	+3.01%	+3.01%	—
14d	1	+0.00%	+12.46%	+3.71%	+8.75%	+8.75%	—
30d	1	+0.00%	+55.58%	+7.66%	+47.91%	+47.91%	—
60d	1	+0.00%	+44.16%	+7.81%	+36.35%	+36.35%	—
90d	1	+0.00%	+33.30%	+11.54%	+21.76%	+21.76%	—
180d	1	+0.00%	+5.67%	+22.66%	-16.99%	-16.99%	—
1y	1	+100.00%	-30.97%	+37.83%	-68.80%	-68.80%	—
2y	1	+100.00%	-89.36%	+12.79%	-102.15%	-102.15%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

ORIC · 1,100,446 shares · as of Nov 4, 2020

Trading cadence · quarterly flow

BUY ● SELL ●

2020

FLOW · 4 buys / 5 sellsCOVERAGE · 3 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
ORIC ORIC PHARMACEUTICALS, INC.	SALE	2,268,750	—	—	1,100,446	Nov 4, 2020	Nov 5, 2020 ↗	View →
ORIC ORIC PHARMACEUTICALS, INC.	SALE	2,268,750	—	—	0	Apr 28, 2020	Apr 28, 2020 ↗	View →
ORIC ORIC PHARMACEUTICALS, INC.	PURCHASE	314,815	—	—	1,043,874	Apr 28, 2020	Apr 28, 2020 ↗	View →
ORIC ORIC PHARMACEUTICALS, INC.	PURCHASE	497,809	—	—	729,059	Apr 28, 2020	Apr 28, 2020 ↗	View →
ORIC ORIC PHARMACEUTICALS, INC.	PURCHASE	2,268,750	—	—	2,268,750	Apr 28, 2020	Apr 28, 2020 ↗	View →
ORIC ORIC PHARMACEUTICALS, INC.	SALE	231,250	—	—	0	Apr 28, 2020	Apr 28, 2020 ↗	View →
ORIC ORIC PHARMACEUTICALS, INC.	SALE	497,809	—	—	0	Apr 28, 2020	Apr 28, 2020 ↗	View →
ORIC ORIC PHARMACEUTICALS, INC.	PURCHASE	231,250	—	—	231,250	Apr 28, 2020	Apr 28, 2020 ↗	View →
ORIC ORIC PHARMACEUTICALS, INC.	SALE	314,815	—	—	0	Apr 28, 2020	Apr 28, 2020 ↗	View →

Other insiders · ORIC

Loading peer insiders…

About this filer

CIK 0001745827

ROLE

10% Owner

PRIMARY

ORIC

COMPANIES

ACTIVE SINCE

Apr 2020

MARKETPEEL · /INSIDER/0001745827DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Topspin Biotech Fund Ii, L.p.

The morning brief, before the bell.